Copyright Reports & Markets. All rights reserved.

Global and China Biosimilar Testing and Development Services Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Effector Binding
    • 1.2.3 ELISA
    • 1.2.4 Kinetic Binding Assays
    • 1.2.5 ADCC & CDC Cell-Based Assays
  • 1.3 Market by Application
    • 1.3.1 Global Biosimilar Testing and Development Services Market Share by Application: 2020 VS 2026
    • 1.3.2 PK assay
    • 1.3.3 Tiered Immunogenicity testing
    • 1.3.4 NAb assays
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Biosimilar Testing and Development Services Market Perspective (2015-2026)
  • 2.2 Global Biosimilar Testing and Development Services Growth Trends by Regions
    • 2.2.1 Biosimilar Testing and Development Services Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biosimilar Testing and Development Services Historic Market Share by Regions (2015-2020)
    • 2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Biosimilar Testing and Development Services Players by Market Size
    • 3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2015-2020)
    • 3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2015-2020)
  • 3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
  • 3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
    • 3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2019
  • 3.5 Key Players Biosimilar Testing and Development Services Area Served
  • 3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
  • 3.7 Date of Enter into Biosimilar Testing and Development Services Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar Testing and Development Services Breakdown Data by Type (2015-2026)

  • 4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2015-2020)
  • 4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2021-2026)

5 Biosimilar Testing and Development Services Breakdown Data by Application (2015-2026)

  • 5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2015-2020)
  • 5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Biosimilar Testing and Development Services Market Size (2015-2026)
  • 6.2 North America Biosimilar Testing and Development Services Market Size by Type (2015-2020)
  • 6.3 North America Biosimilar Testing and Development Services Market Size by Application (2015-2020)
  • 6.4 North America Biosimilar Testing and Development Services Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Biosimilar Testing and Development Services Market Size (2015-2026)
  • 7.2 Europe Biosimilar Testing and Development Services Market Size by Type (2015-2020)
  • 7.3 Europe Biosimilar Testing and Development Services Market Size by Application (2015-2020)
  • 7.4 Europe Biosimilar Testing and Development Services Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Biosimilar Testing and Development Services Market Size (2015-2026)
  • 8.2 China Biosimilar Testing and Development Services Market Size by Type (2015-2020)
  • 8.3 China Biosimilar Testing and Development Services Market Size by Application (2015-2020)
  • 8.4 China Biosimilar Testing and Development Services Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Biosimilar Testing and Development Services Market Size (2015-2026)
  • 9.2 Japan Biosimilar Testing and Development Services Market Size by Type (2015-2020)
  • 9.3 Japan Biosimilar Testing and Development Services Market Size by Application (2015-2020)
  • 9.4 Japan Biosimilar Testing and Development Services Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Biosimilar Testing and Development Services Market Size (2015-2026)
  • 10.2 Southeast Asia Biosimilar Testing and Development Services Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Biosimilar Testing and Development Services Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Biosimilar Testing and Development Services Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Eurofins Scientific
    • 11.1.1 Eurofins Scientific Company Details
    • 11.1.2 Eurofins Scientific Business Overview
    • 11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
    • 11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2015-2020))
    • 11.1.5 Eurofins Scientific Recent Development
  • 11.2 SGS
    • 11.2.1 SGS Company Details
    • 11.2.2 SGS Business Overview
    • 11.2.3 SGS Biosimilar Testing and Development Services Introduction
    • 11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2015-2020)
    • 11.2.5 SGS Recent Development
  • 11.3 Charles River Laboratories
    • 11.3.1 Charles River Laboratories Company Details
    • 11.3.2 Charles River Laboratories Business Overview
    • 11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
    • 11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2015-2020)
    • 11.3.5 Charles River Laboratories Recent Development
  • 11.4 Pharmaceutical Product Development
    • 11.4.1 Pharmaceutical Product Development Company Details
    • 11.4.2 Pharmaceutical Product Development Business Overview
    • 11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
    • 11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2015-2020)
    • 11.4.5 Pharmaceutical Product Development Recent Development
  • 11.5 Exova
    • 11.5.1 Exova Company Details
    • 11.5.2 Exova Business Overview
    • 11.5.3 Exova Biosimilar Testing and Development Services Introduction
    • 11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2015-2020)
    • 11.5.5 Exova Recent Development
  • 11.6 Source BioScience
    • 11.6.1 Source BioScience Company Details
    • 11.6.2 Source BioScience Business Overview
    • 11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
    • 11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2015-2020)
    • 11.6.5 Source BioScience Recent Development
  • 11.7 Intertek Group
    • 11.7.1 Intertek Group Company Details
    • 11.7.2 Intertek Group Business Overview
    • 11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
    • 11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2015-2020)
    • 11.7.5 Intertek Group Recent Development
  • 11.8 Medistri
    • 11.8.1 Medistri Company Details
    • 11.8.2 Medistri Business Overview
    • 11.8.3 Medistri Biosimilar Testing and Development Services Introduction
    • 11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2015-2020)
    • 11.8.5 Medistri Recent Development
  • 11.9 Pace Analytical Services
    • 11.9.1 Pace Analytical Services Company Details
    • 11.9.2 Pace Analytical Services Business Overview
    • 11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
    • 11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2015-2020)
    • 11.9.5 Pace Analytical Services Recent Development
  • 11.10 Sigma-Aldrich
    • 11.10.1 Sigma-Aldrich Company Details
    • 11.10.2 Sigma-Aldrich Business Overview
    • 11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
    • 11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2015-2020)
    • 11.10.5 Sigma-Aldrich Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Biosimilar Testing and Development Services Scope and Market Size
    Biosimilar Testing and Development Services market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Testing and Development Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Effector Binding
    ELISA
    Kinetic Binding Assays
    ADCC & CDC Cell-Based Assays

    Market segment by Application, split into
    PK assay
    Tiered Immunogenicity testing
    NAb assays

    Based on regional and country-level analysis, the Biosimilar Testing and Development Services market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Biosimilar Testing and Development Services market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Eurofins Scientific
    SGS
    Charles River Laboratories
    Pharmaceutical Product Development
    Exova
    Source BioScience
    Intertek Group
    Medistri
    Pace Analytical Services
    Sigma-Aldrich

    Buy now